drug protocol number

DUT0012

drug sponsor

Sanofi-Aventis group

drug study

DUPIXENT® (Dupilumab)

drug trial site

Specialized Medical Center (Riyadh),Dr. Erfan & Bagedo General Hospital (Jeddah)

drug status

Completed

drug phase